Jim Cramer says the AI trade is not going away as Nasdaq enters correction

The Nasdaq fell 4.2% on Thursday, entering correction territory after dropping more than 10% from its record high last month; the S&P 500 lost 2.9% and the Dow fell 2.2% as investors rotated out of technology stocks. Concerns that financing challenges and political scrutiny could slow AI data-center construction weighed on semiconductor and cybersecurity shares, despite strong AMD and Qnity earnings. Cardinal Health rose 5% after strong fiscal first-quarter results and a higher full-year outlook; Kimberly-Clark reported better-than-feared results and reaffirmed its outlook.

Analysis

The key transmission is not simply “AI demand weakens”: financing friction and political scrutiny can delay projects, stretching revenue conversion for infrastructure suppliers while leaving buyers with near-term capex and power commitments. That raises execution risk and the discount rate investors apply to long-duration AI earnings. The market’s failure to reward AMD’s reported strength suggests factor/positioning de-risking is dominating company-specific results; estimate revisions may lag the initial multiple compression. Cybersecurity’s selloff alongside semiconductors looks like exposure reduction, not evidence that security demand has deteriorated. If that distinction holds, CRWD and PANW could recover sooner than hardware names once flows stabilize.

Over days, broad risk-off and crowded positioning can continue to overwhelm fundamentals. Over 1–3 months, watch hyperscaler capex guidance, financing availability, and project timing; delays would pressure the infrastructure supply chain, including AVGO, ARM, and GLW. Over 6–18 months, a slower buildout could defer demand rather than destroy it, while improving buyer cash generation; the structural thesis is not disproven by one volatile session. MU remains exposed to the same capex cycle despite its distinct memory economics.

Contrarian: extrapolating a correction into an AI spending collapse is premature. Conversely, treating the selloff as an automatic entry point ignores financing and policy constraints. CAH’s raised outlook is more company-specific support, but a sharp repricing can overshoot; KMB’s reaffirmed outlook does not resolve whether Kenvue synergies will deliver. No valuation or capex detail here supports price targets.

Key Decisions for Investors

• Avoid adding broad AI infrastructure exposure into forced selling. Reassess AVGO, ARM, and GLW after hyperscaler guidance clarifies whether projects are canceled or merely delayed; a material capex cut or repeated schedule slippage would falsify the defer-not-destroy view.
• Watch for stabilization in CRWD and PANW relative to chip and infrastructure names as a potential pair-trade setup, not an immediate recommendation. Require evidence that security demand and guidance remain intact; persistent underperformance after tech flows normalize would weaken the thesis.
• Do not chase CAH after the sharp rally. Track the next update for outlook delivery and distribution economics; a retracement without guidance deterioration may offer a better entry, while a guidance cut would invalidate the defensive-growth case.
• Keep KMB/KVUE on a catalyst watchlist rather than underwriting acquisition synergies now. Seek quantified synergy timing and progress before positioning; absent that disclosure, KMB’s reaffirmed outlook alone is not a catalyst.